The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Targeting transcription factor STAT3 for cancer prevention and therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080 · cited 1×
“2) (Darnell et al., 1994; Aittomaki & Pesu, 2014;Mohan et al., 2014; Siveen, Sikka, et al., 2014; Dai et al., 2015; Lee et al., 2015).”
Nicholson, R. I., Gee, J. M. W., & Harper, M. E. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00231-3 · Cited by 2,143
Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., & Akira, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3801 · Cited by 1,323 · cited 4×
“, 1996), further studies have demonstrated that STAT3 can also be activated by a diverse range of cytokines in addition to the IL-6 family (Takeda et al., 1997; Mohan et al., 2014; Siveen, Sikka, et al., 2014; Dai et al., 2015; Lee et al., 2015).”
InfluentialLevy, D. E., & Lee, C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15650 · Cited by 810
Three-dimensional structure of the Stat3β homodimer bound to DNA
Becker, S., Groner, B., & Müller, C. W. (1998) · Nature · doi:10.1038/28101 · Cited by 788
Levy, D. E., & Lee, C.-K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215650 · Cited by 734
The Stat family in cytokine signaling
Ihle, J. N. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00199-x · Cited by 713 · cited 2×
“A total of seven STAT proteins, STAT1, -2, -3, -4, - 5a, -5b, and -6, have been identified till date in mammalian cells (Ihle, 2001; Subramaniam et al., 2013a; Sethi et al., 2014; Siveen, Nguyen, et al., 2014; Siveen, Sikka, et al., 2014) (Fig.”
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
Siveen, K. S., Sikka, S., Surana, R., Dai, X., Zhang, J., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.12.005 · Cited by 634
Self-citationThymoquinone: Potential cure for inflammatory disorders and cancer
Woo, C. C., Kumar, A. P., Sethi, G., & Tan, K. H. B. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.09.029 · Cited by 541
Self-citationThe Multifaceted Role of Curcumin in Cancer Prevention and Treatment
Shanmugam, M., Rane, G., Kanchi, M., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., & Sethi, G. (2015) · Molecules · doi:10.3390/molecules20022728 · Cited by 510
Self-citationBeyond chemotherapy: targeted therapies in ovarian cancer
Yap, T. A., Carden, C. P., & Kaye, S. B. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2583 · Cited by 495
The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis
Chang, Q., Bournazou, E., Sansone, P., Berishaj, M., Gao, S. P., Daly, L., Wels, J., Theilen, T., Granitto, S., Zhang, X., et al. (2013) · Neoplasia · doi:10.1593/neo.13706 · Cited by 494
Advances in Cancer Therapy with Plant Based Natural Products
Mukherjee, A., Basu, S., Sarkar, N., & Ghosh, A. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372094 · Cited by 451
Corvinus, F. M., Orth, C., Moriggl, R., Tsareva, S. A., Wagner, S., Pfitzner, E. B., Baus, D., Kaufman, R., Huber, L. A., Zatloukal, K., et al. (2005) · Neoplasia · doi:10.1593/neo.04571 · Cited by 427
Thymoquinone: A promising anti-cancer drug from natural sources
Gali-Muhtasib, H., Roessner, A., & Schneider-Stock, R. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.10.009 · Cited by 420
Polyphenols in Human Health and Disease
(2014) · Elsevier eBooks · doi:10.1016/c2011-1-09286-x · Cited by 419
STAT3 SIGNALING: Anticancer Strategies and Challenges
Johnston, P. A., & Grandis, J. R. (2011) · Molecular Interventions · doi:10.1124/mi.11.1.4 · Cited by 406
AGGARWAL, B. B., SETHI, G., AHN, K. S., SANDUR, S. K., PANDEY, M. K., KUNNUMAKKARA, A. B., SUNG, B., & ICHIKAWA, H. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.063 · Cited by 398
Self-citationBhardwaj, A., Sethi, G., Vadhan-Raj, Bueso-Ramos, C., Takada, Y., Gaur, U., Nair, A. S., Shishodia, S., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2006-02-003988 · Cited by 395
Self-citationRole of STAT3 in Cancer Metastasis and Translational Advances
Kamran, M. Z., Patil, P., & Gude, R. P. (2013) · BioMed Research International · doi:10.1155/2013/421821 · Cited by 393
Reich, N. C., & Liu, L. (2006) · Nature Reviews Immunology · doi:10.1038/nri1885 · Cited by 376
STAT3 as a central mediator of neoplastic cellular transformation
Frank, D. A. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.10.017 · Cited by 364
Chan, K. S., Sano, S., Kiguchi, K., Anders, J., Komazawa, N., Takeda, J., & DiGiovanni, J. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421032 · Cited by 356
Tocotrienols in health and disease: The other half of the natural vitamin E family
Sen, C. K., Khanna, S., & Roy, S. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2007.03.001 · Cited by 351
Minami, M., Inoue, M., Wei, S., Takeda, K., Matsumoto, M., Kishimoto, T., & Akira, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3963 · Cited by 335
Sen, M., Thomas, S. M., Kim, S., Yeh, J. I., Ferris, R. L., Johnson, J. T., Duvvuri, U., Lee, J., Sahu, N., Joyce, S., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0191 · Cited by 313
Self-citationSTAT3 Is Necessary for Proliferation and Survival in Colon Cancer–Initiating Cells
Lin, L., Liu, A., Peng, Z., Lin, H.-J., Li, P.-K., Li, C., & Lin, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4660 · Cited by 297
STAT‐mediated EGFR signaling in cancer
Quesnelle, K. M., Boehm, A. L., & Grandis, J. R. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21475 · Cited by 295
Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
Xiong, A., Yang, Z., Shen, Y., Zhou, J., & Shen, Q. (2014) · Cancers · doi:10.3390/cancers6020926 · Cited by 283
Kotha, A., Sekharam, M., Cilenti, L., Siddiquee, K., Khaled, A., Zervos, A. S., Carter, B., Turkson, J., & Jove, R. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0268 · Cited by 283
Keystone, E. C., Taylor, P. C., Drescher, E., Schlichting, D. E., Beattie, S. D., Berclaz, P.-Y., Lee, C. H., Fidelus-Gort, R. K., Luchi, M. E., Rooney, T. P., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206478 · Cited by 281
Siegel, A. M., Heimall, J., Freeman, A. F., Hsu, A. P., Brittain, E., Brenchley, J. M., Douek, D. C., Fahle, G. H., Cohen, J. I., Holland, S. M., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.09.016 · Cited by 278
Subramaniam, A., Shanmugam, M. K., Perumal, E., Li, F., Nachiyappan, A., Dai, X., Swamy, S. N., Ahn, K. S., Kumar, A. P., Tan, B. K. H., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.10.002 · Cited by 278
Self-citationAhn, K. S., Sethi, G., Krishnan, K., & Aggarwal, B. B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610028200 · Cited by 264
Self-citationTurkson, J., Kim, J. S., Zhang, S., Yuan, J., Huang, M., Glenn, M., Haura, E., Sebti, S., Hamilton, A. D., & Jove, R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.261.3.3 · Cited by 255
Shanmugam, M. K., Kannaiyan, R., & Sethi, G. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.523502 · Cited by 235
Self-citationSantos, F. P. S., Kantarjian, H. M., Jain, N., Manshouri, T., Thomas, D. A., Garcia-Manero, G., Kennedy, D., Estrov, Z., Cortes, J., & Verstovsek, S. (2010) · Blood · doi:10.1182/blood-2009-10-246363 · Cited by 233
Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis
Pardanani, A., Laborde, R. R., Lasho, T. L., Finke, C., Begna, K., Al-Kali, A., Hogan, W. J., Litzow, M. R., Leontovich, A., Kowalski, M., et al. (2013) · Leukemia · doi:10.1038/leu.2013.71 · Cited by 233
Olivera, A., Moore, T. W., Hu, F., Brown, A. P., Sun, A., Liotta, D. C., Snyder, J. P., Yoon, Y., Shim, H., Marcus, A. I., et al. (2012) · International Immunopharmacology · doi:10.1016/j.intimp.2011.12.009 · Cited by 229
Chen, P.-S., Shih, Y.-W., Huang, H.-C., & Cheng, H.-W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020164 · Cited by 225
Pozo‐Guisado, E., Merino, J. M., Mulero‐Navarro, S., Lorenzo‐Benayas, M. J., Centeno, F., Alvarez‐Barrientos, A., & Salguero, P. M. F. (2005) · International Journal of Cancer · doi:10.1002/ijc.20856 · Cited by 223
STAT3 as a therapeutic target in head and neck cancer
Leeman, R. J., Lui, V. W. Y., & Grandis, J. R. (2006) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.6.3.231 · Cited by 223
Thymoquinone: fifty years of success in the battle against cancer models
Schneider-Stock, R., Fakhoury, I. H., Zaki, A. M., El-Baba, C. O., & Gali-Muhtasib, H. U. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2013.08.021 · Cited by 217
Woo, C. C., Hsu, A., Kumar, A. P., Sethi, G., & Tan, K. H. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075356 · Cited by 216
Self-citationLi, F., Fernandez, P. P., Rajendran, P., Hui, K. M., & Sethi, G. (2010) · Cancer Letters · doi:10.1016/j.canlet.2009.12.003 · Cited by 201
Self-citationMorikawa, T., Baba, Y., Yamauchi, M., Kuchiba, A., Nosho, K., Shima, K., Tanaka, N., Huttenhower, C., Frank, D. A., Fuchs, C. S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2694 · Cited by 198
Capsaicin Is a Novel Blocker of Constitutive and Interleukin-6–Inducible STAT3 Activation
Bhutani, M., Pathak, A. K., Nair, A. S., Kunnumakkara, A. B., Guha, S., Sethi, G., & Aggarwal, B. B. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2575 · Cited by 197
Self-citationEddahri, F., Denanglaire, S., Bureau, F., Spolski, R., Leonard, W. J., Leo, O., & Andris, F. (2009) · Blood · doi:10.1182/blood-2008-04-154682 · Cited by 196
Li, F., Rajendran, P., & Sethi, G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00874.x · Cited by 176
Self-citationSethi, G., Chatterjee, S., Rajendran, P., Li, F., Shanmugam, M. K., Wong, K. F., Kumar, A. P., Senapati, P., Behera, A. K., Hui, K. M., et al. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-66 · Cited by 171
Self-citationFurqan, M., Mukhi, N., Lee, B., & Liu, D. (2013) · Biomarker Research · doi:10.1186/2050-7771-1-5 · Cited by 170
Perspectives on new synthetic curcumin analogs and their potential anticancer properties.
Vyas, A., Dandawate, P. R., Padhyé, S., et al. (2013) · PubMed · Cited by 169
Ellison, N., Loprinzi, C. L., Kugler, J., Hatfield, A. K., Miser, A., Sloan, J. A., Wender, D. B., Rowland, K. M., Molina, R., Cascino, T. L., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2974 · Cited by 168
Tocotrienols: The Emerging Face of Natural Vitamin E
Sen, C. K., Khanna, S., Rink, C., & Roy, S. (2007) · Vitamins & Hormones · doi:10.1016/s0083-6729(07)76008-9 · Cited by 165
Lee, J. H., Kim, C., Sethi, G., & Ahn, K. S. (2015) · Oncotarget · doi:10.18632/oncotarget.3443 · Cited by 162
Self-citationScuto, A., Krejčí, P., Popplewell, L. L., Wu, J., wang, Y., Kujawski, M., Kowolik, C. M., Xin, H., Chen, L., Wang, Y., et al. (2010) · Leukemia · doi:10.1038/leu.2010.289 · Cited by 161
Lin, L., Deangelis, S., Foust, E., Fuchs, J. R., Li, C., Li, P., Schwartz, E. B., Lesinski, G. B., Benson, D., Lü, J., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-217 · Cited by 160
Mohan, C. D., Bharathkumar, H., Bulusu, K. C., Pandey, V., Rangappa, S., Fuchs, J. E., Shanmugam, M. K., Dai, X., Li, F., Deivasigamani, A., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.601104 · Cited by 159
Self-citationRajendran, P., Li, F., Shanmugam, M. K., Kannaiyan, R., Goh, J. N., Wong, K. F., Wang, W., Khin, E., Tergaonkar, V., Kumar, A. P., et al. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0420 · Cited by 158
Self-citationWong, A. L., Soo, R. A., Tan, D. S., Lee, S. C., Lim, J. S., Marban, P. C., Kong, L. R., Lee, Y. J., Wang, L. Z., Thuya, W. L., et al. (2015) · Annals of Oncology · doi:10.1093/annonc/mdv026 · Cited by 153
Self-citationTherapeutic Targeting of the JAK / STAT Pathway
Aittomäki, S., & Pesu, M. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12164 · Cited by 152
Sung, B., Kunnumakkara, A. B., Sethi, G., Anand, P., Guha, S., & Aggarwal, B. B. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0905 · Cited by 150
Self-citationZhang, X., Sun, Y., Pireddu, R., Yang, H., Urlam, M. K., Lawrence, H. R., Guida, W. C., Lawrence, N. J., & Sebti, S. M. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3175 · Cited by 149
Subramaniam, A., Shanmugam, M. K., Ong, T. H., Li, F., Perumal, E., Chen, L., Vali, S., Abbasi, T., Kapoor, S., Ahn, K. S., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12302 · Cited by 147
Self-citationTimofeeva, O., Tarasova, N., Zhang, X., Chasovskikh, S., Cheema, A., Wang, H.-H., Brown, M. L., & Dritschilo, A. (2013) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1211805110 · Cited by 146
Nagel‐Wolfrum, K., Buerger, C., Wittig, I., Butz, K., Hoppe‐Seyler, F., & Groner, B. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.170.2.3 · Cited by 145
Chiang, C.-T., Way, T., Tsai, S.-J., & Lin, J. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.021 · Cited by 144
Mackenzie, G. G., Queisser, N., Wolfson, M. L., Fraga, C. G., Adamo, A. M., & Oteiza, P. I. (2008) · International Journal of Cancer · doi:10.1002/ijc.23477 · Cited by 144
Younes, A., Romaguera, J. E., Fanale, M. A., McLaughlin, P. J., Hagemeister, F. B., Copeland, A. R. M., Neelapu, S. S., Kwak, L. W., Shah, J. J., Faria, S. D. C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.5223 · Cited by 143
Saydmohammed, M., Joseph, D., & Syed, V. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22558 · Cited by 142
Real time analysis of STAT3 nucleocytoplasmic shuttling
Pranada, A. L., Metz, S., Herrmann, A., Heinrich, P. C., & Müller-Newen, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312530200 · Cited by 140
Chua, A. W. L., Hay, H. S., Rajendran, P., Shanmugam, M. K., Li, F., Bist, P., Koay, E. S.-C., Lim, L. H. K., Kumar, A. P., & Sethi, G. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.07.045 · Cited by 140
Self-citationRajendran, P., Ong, T. H., Chen, L., Li, F., Shanmugam, M. K., Vali, S., Abbasi, T., Kapoor, S., Sharma, A. K., Kumar, A. P., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1123 · Cited by 140
Self-citationKannaiyan, R., Hay, H. S., Rajendran, P., Li, F., Shanmugam, M. K., Vali, S., Abbasi, T., Kapoor, S., Sharma, A. K., Kumar, A. P., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01449.x · Cited by 138
Self-citationFlowers, L. O., Subramaniam, P. S., & Johnson, H. M. (2005) · Oncogene · doi:10.1038/sj.onc.1208437 · Cited by 137
Rajendran, P., Li, F., Manu, K. A., Shanmugam, M. K., Loo, S. Y., Kumar, A. P., & Sethi, G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01187.x · Cited by 134
Self-citationPan, Y., Zhou, F., Zhang, R., & Claret, F. X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054565 · Cited by 132
Huang, W., Dong, Z., Wang, F., Peng, H., Liu, J., & Zhang, J. (2014) · ACS Chemical Biology · doi:10.1021/cb500071v · Cited by 131
Phase I Study of OPB-31121, an Oral STAT3 Inhibitor, in Patients with Advanced Solid Tumors
Oh, D., Lee, S., Han, S., Kim, M., Kim, T.-M., Kim, T., Heo, D. S., Yuasa, M., Yanagihara, Y., & Bang, Y. (2015) · Cancer Research and Treatment · doi:10.4143/crt.2014.249 · Cited by 128
STAT3 expression in gastric cancer indicates a poor prognosis
Kim, D., Cha, S., Ahn, D., Kang, H., Kwon, C., Ko, K., Hwang, S., Park, P. J., Rim, K., & Hong, S. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05671.x · Cited by 126
Glienke, W., Maute, L., Wicht, J., & Bergmann, L. (2009) · Cancer Investigation · doi:10.3109/07357900903287006 · Cited by 125
Komrokji, R. S., Seymour, J. F., Roberts, A. W., Wadleigh, M., To, L. B., Scherber, R. M., Turba, E., Dorr, A., Zhu, J., Wang, L., et al. (2015) · Blood · doi:10.1182/blood-2013-02-484832 · Cited by 123
Self-citationPandey, M. K., Sung, B., Ahn, K. S., & Aggarwal, B. B. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.052548 · Cited by 123
Self-citationKim, M., Nam, H.-J., Kim, H., Han, S., Im, S., Kim, T., Oh, D., & Bang, Y. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.010 · Cited by 118
Bendell, J. C., Hong, D. S., Burris, H. A., Naing, A., Jones, S. F., Falchook, G., Bricmont, P., Elekes, A., Rock, E. P., & Kurzrock, R. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2480-2 · Cited by 115
AZD1480: A Phase I Study of a Novel JAK2 Inhibitor in Solid Tumors
Plimack, E. R., LoRusso, P. M., Mccoon, P. E., Tang, W., Krebs, A. D., Curt, G. A., & Eckhardt, S. (2013) · The Oncologist · doi:10.1634/theoncologist.2013-0198 · Cited by 115
Celastrol inhibits gastric cancer growth by induction of apoptosis and autophagy
Lee, H., Jang, K. S. B., Choi, H. J., Jo, A., Cheong, J., & Chun, K. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.12.069 · Cited by 115
He, Z., Chen, H., Li, G., Zhu, H., Gao, Y., Zhang, L., & Sun, J. (2014) · Phytomedicine · doi:10.1016/j.phymed.2014.02.002 · Cited by 110
Hayakawa, F., Sugimoto, K., Harada, Y., Hashimoto, N., Ohi, N., Kurahashi, S., & Naoe, T. (2013) · Blood Cancer Journal · doi:10.1038/bcj.2013.63 · Cited by 108
Dai, X., Ahn, K., Kim, C., Siveen, K., Ong, T. H., Shanmugam, M. K., Li, F., Shi, J.-Z., Kumar, A., Wang, L.-Z., et al. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2014.12.008 · Cited by 106
Self-citationZhang, P., Li, H., Yang, B., Yang, F., Zhang, L., Kong, Q., Chen, X.-Y., Wu, M., & Liu, J. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.15 · Cited by 106
Mead, A. J., Milojković, D., Knapper, S., Garg, M. K., Chacko, J. M., Farquharson, M., Yin, J. L., Ali, S., Clark, R. E., Andrews, C., et al. (2015) · British Journal of Haematology · doi:10.1111/bjh.13379 · Cited by 105
Role and Regulation of STAT3 Phosphorylation at Ser727 in Melanocytes and Melanoma Cells
Sakaguchi, M., Oka, M., Iwasaki, T., Fukami, Y., & Nishigori, C. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.45 · Cited by 103
Yan, S., Li, Z., & Thiele, C. J. (2013) · Oncotarget · doi:10.18632/oncotarget.930 · Cited by 103
Lu, Z., Jin, Y., Qiu, L., Lai, Y., & Pan, J. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.09.006 · Cited by 103
Buerger, C., Nagel‐Wolfrum, K., Kunz, C., Wittig, I., Butz, K., Hoppe‐Seyler, F., & Groner, B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301629200 · Cited by 102
Brambilla, L., Genini, D., Laurini, E., Merulla, J., Perez, L. H., Fermeglia, M., Carbone, G. M., Pricl, S., & Catapano, C. V. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.02.012 · Cited by 102
Fossey, S. L., Bear, M. D., Lin, J., Li, C., Schwartz, E. B., Li, P., Fuchs, J. R., Fenger, J. M., Kisseberth, W. C., & London, C. A. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-112 · Cited by 101
Curcumin a potent cancer preventive agent: Mechanisms of cancer cell killing
Tuorkey, M. J. (2014) · Interventional Medicine and Applied Science · doi:10.1556/imas.6.2014.4.1 · Cited by 101
Du, W., Hong, J., Wang, Y., Zhang, Y., Wang, P., Su, W., Lin, Y., Lu, R., Zou, W., Xiong, H., et al. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01483.x · Cited by 101
Yakata, Y., Nakayama, T., Yoshizaki, A., Kusaba, T., Inoue, K., & Sekine, I. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.2.437 · Cited by 99
Han, Z., Feng, J., Hong, Z., Chen, L., Li, W., Liao, S., Wang, X., Ji, T., Wang, S., Ma, D., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.04.087 · Cited by 99
Inhibition of the JAK2/STAT3 Pathway Reduces Gastric Cancer Growth In Vitro and In Vivo
Judd, L. M., Menheniott, T. R., Ling, H. Y., Jackson, C. B., Howlett, M., Kalantzis, A., Priebe, W., & Giraud, A. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095993 · Cited by 97
Perspectives on New Synthetic Curcumin Analogs and their Potential Anticancer Properties
Vyas, A., Dandawate, P. R., Padhyé, S., Ahmad, A., & Sarkar, F. H. (2013) · Current Pharmaceutical Design · doi:10.2174/138161213805289309 · Cited by 97
Review of STAT3 (Signal Transducers and Activators of Transcription) in head and neck cancer
Mali, S. B. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.03.004 · Cited by 96
Targeted Blockade of JAK/STAT3 Signaling Inhibits Ovarian Carcinoma Growth
Gritsina, G., Xiao, F., O’Brien, S. W., Gabbasov, R. T., Maglaty, M. A., Xu, R.-H., Thapa, R. J., Zhou, Y., Nicolas, É., Litwin, S., et al. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0800 · Cited by 96
Weerasinghe, P., Garcia, G., Zhu, Q., Yuan, P., Feng, L., Mao, L., & Jing, N. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.1.129 · Cited by 95
Nucleocytoplasmic shuttling of persistently activated STAT3
Herrmann, A., Vogt, M., Mönnigmann, M., Clahsen, T., Sommer, U., Haan, S., Poli, V., Heinrich, P. C., & Müller-Newen, G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03482 · Cited by 94
Junicho, A., Matsuda, T., Yamamoto, T., Kishi, H., Korkmaz, K., Saatcioglu, F., Fuse, H., & Muraguchi, A. (2000) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1006/bbrc.2000.3753 · Cited by 90
Kim, Y., Kang, H., Jang, S.-W., & Ko, J. (2011) · Cellular Physiology and Biochemistry · doi:10.1159/000331729 · Cited by 88
Siveen, K. S., Nguyen, A. H., Lee, J. H., Li, F., Singh, S. S., Kumar, A. P., Low, G., Jha, S. K., Tergaonkar, V., Ahn, K. S., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.422 · Cited by 86
Self-citationResveratrol inhibits migration and invasion of human breast‐cancer cells
Tang, F., Su, Y., Chen, N., Hsieh, H., & Chen, K. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700325 · Cited by 86
Stat3-siRNA induces Fas-mediated apoptosis in vitro and in vivo in breast cancer
Rao (2009) · International Journal of Oncology · doi:10.3892/ijo_00000249 · Cited by 86
Hochhaus, A., & Kantarjian, H. M. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-013-1488-z · Cited by 85
Bill, M. A., Nicholas, C., Mace, T. A., Etter, J. P., Li, C., Schwartz, E. B., Fuchs, J. R., Young, G. S., Lin, L., Lin, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040724 · Cited by 84
Rationally Designed Inhibitors Identify STAT3 N-Domain as a Promising Anticancer Drug Target
Timofeeva, O. A., Gaponenko, V., Lockett, S., Tarasov, S. G., Jiang, S., Michejda, C. J., Perantoni, A. O., & Tarasova, N. I. (2007) · ACS Chemical Biology · doi:10.1021/cb700186x · Cited by 80
Gao, L., Xu, D.-Q., Wen, L., Zhang, X., Shao, Y., & Zhao, X. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00053.x · Cited by 80
Gariboldi, M. B., Ravizza, R., & Monti, E. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.05.011 · Cited by 79
Moser, C., Schachtschneider, P., Lang, S. A., Gaumann, A. K. A., Mori, A., Zimmermann, J., Schlitt, H. J., Geissler, E. K., & Stoeltzing, O. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.04.003 · Cited by 78
The JAK-STAT pathway: summary of initial studies and recent advances.
Darnell, J. E. (1996) · PubMed · Cited by 76
Sen, M., Pollock, N., Black, J., DeGrave, K. A., Wheeler, S., Freilino, M. L., Joyce, S. C., Lui, V. W. Y., Zeng, Y., Chiosea, S. I., et al. (2015) · Neoplasia · doi:10.1016/j.neo.2015.01.003 · Cited by 75
Souissi, I., Najjar, I., Koon, L. A., Schischmanoff, P. O., Lesage, D., Coquil, S. L., Roger, C., Dusanter‐Fourt, I., Varin‐Blank, N., Cao, A., et al. (2011) · BMC Cell Biology · doi:10.1186/1471-2121-12-14 · Cited by 71
Alkhalaf, M., El‐Mowafy, A. M., Renno, W. M., Rachid, O., Ali, A. M., & Al-Attyiah, R. (2007) · Archives of Medical Research · doi:10.1016/j.arcmed.2007.09.003 · Cited by 69
Okusaka, T., Ueno, H., Ikeda, M., Mitsunaga, S., Ozaka, M., Ishii, H., Yokosuka, O., Ooka, Y., Yoshimoto, R., Yanagihara, Y., et al. (2015) · Hepatology Research · doi:10.1111/hepr.12504 · Cited by 67
Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma
Lau, C. K., Yang, Z. F., Lam, S. P., Lam, C. T., Ngai, P., Tam, K. H., Poon, R. T. P., & Fan, S.-T. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.12.4970 · Cited by 65
Capsaicin: A novel radio-sensitizing agent for prostate cancer
Venier, N. A., Colquhoun, A., Sasaki, H., Kiss, A., Sugar, L., Adomat, H. H., Fleshner, N. E., Klotz, L. H., & Venkateswaran, V. (2014) · The Prostate · doi:10.1002/pros.22896 · Cited by 59
Natural Product Modulators to Overcome Multidrug Resistance In Cancer
Çört, A., & Özben, T. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.1002624 · Cited by 57
Iacono, M. L., Monica, V., Vavalà, T., Gisabella, M., Saviozzi, S., Bracco, E., Novello, S., Papotti, M. G., & Scagliotti, G. V. (2014) · International Journal of Cancer · doi:10.1002/ijc.29302 · Cited by 56
WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis
Zhou, X., Ren, Y., Liu, A., Jin, R., Jiang, Q., Huang, Y., Kong, L., Wang, X., & Zhang, L. (2014) · Scientific Reports · doi:10.1038/srep07461 · Cited by 54
Wang, X., Zhang, Y., ZHANG, X., Tian, W., Feng, W., & Chen, T. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1298 · Cited by 53
Antitumor and Antiangiogenic Activities of Curcumin in Cervical Cancer Xenografts in Nude Mice
Yoysungnoen, B., Bhattarakosol, P., & Patumraj, S. (2014) · BioMed Research International · doi:10.1155/2014/817972 · Cited by 52
Prakash, S., Shao, M. W., Paul, A., Abbasi, S. Q., Chahal, P. S., Mena, J. A., Montes, J., & Kamen, A. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s26891 · Cited by 52
Janus kinase-1 and Janus kinase-2 inhibitors for treating myelofibrosis
Martí-Carvajal, A. J., Anand, V., & Solà, I. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010298.pub2 · Cited by 51
Guggulsterone inhibits angiogenesis by blocking STAT3 and VEGF expression in colon cancer cells
Cheon, J. H. (1994) · Oncology Reports · doi:10.3892/or_00000147 · Cited by 51
Santoni, M., Massari, F., Re, M. D., Ciccarese, C., Piva, F., Principato, G., Montironi, R., Santini, D., Danesi, R., Tortora, G., et al. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1020370 · Cited by 50
Bae (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.601 · Cited by 46
LI, Y., Zhu, W., LI, J., Liu, M., & WEI, M. (2013) · Oncology Reports · doi:10.3892/or.2013.2748 · Cited by 45
Tian, W., Li, B., Zhang, X., Dang, W., Wang, X., Tang, H., Wang, L., Cao, H., & Chen, T. (2012) · Oncology Reports · doi:10.3892/or.2012.1911 · Cited by 43
Self-citationCetuximab-Induced MET Activation Acts as a Novel Resistance Mechanism in Colon Cancer Cells
Song, N., Liu, S., Zhang, J., Liu, J., Xu, L., Liu, Y., & Qu, X. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15045838 · Cited by 42
Kumar, A., & Bora, U. (2012) · Bioinformation · doi:10.6026/97320630008988 · Cited by 36
Self-citationSTAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo
Qiu, Z.-J. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1000 · Cited by 36
Effect of AZD1480 in an epidermal growth factor receptor-driven lung cancer model
Murakami, T., Takigawa, N., Ninomiya, T., Ochi, N., Yasugi, M., Honda, Y., Kubo, T., Ichihara, E., Hotta, K., Tanimoto, M., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.10.011 · Cited by 35
T40214/PEI complex: A potent therapeutics for prostate cancer that targets STAT3 signaling
Weerasinghe, P., Li, Y., Guan, Y., Zhang, R., Tweardy, D. J., & Jing, N. (2008) · The Prostate · doi:10.1002/pros.20807 · Cited by 34
Verstovšek, S., Hoffman, R., Mascarenhas, J. O., Soria, J., Bahleda, R., Mccoon, P. E., Tang, W., Cortes, J. E., Kantarjian, H. M., & Ribrag, V. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.11.018 · Cited by 34
Fujisaka, Y., Onozawa, Y., Kurata, T., Yasui, H., Goto, I., Yamazaki, K., Machida, N., Watanabe, J., Shimada, H., Shi, X., et al. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9809-7 · Cited by 30
Zhang, X., Liu, P., Zhang, B., Mao, H., Shen, L., & Ma, Y. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1431 · Cited by 30
Hexner, E. O., Roboz, G. J., Hoffman, R., Luger, S. M., Mascarenhas, J. O., Carroll, M. P., Clementi, R. A., Bensen-Kennedy, D. M., & Moliterno, A. R. (2013) · British Journal of Haematology · doi:10.1111/bjh.12607 · Cited by 30
Binding Modes of Peptidomimetics Designed to Inhibit STAT3
Dhanik, A., McMurray, J. S., & Kavraki, L. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051603 · Cited by 29
In vitro combined treatment with cetuximab and trastuzumab inhibits growth of colon cancer cells
Luca, T., Barresi, V., Privitera, G., Musso, N., Caruso, M., Condorelli, D. F., & Castorina, S. (2014) · Cell Proliferation · doi:10.1111/cpr.12125 · Cited by 27 · cited 1×
“For example, cetuximab, a monoclonal antibody against EGFR is often prescribed either alone or in combination for the treatment and management of colon cancer (Ojima et al., 2013; Luca et al., 2014).”
Wang, S., Hu, J., Guo, Q., Zhao, Y. F., CHENG, J.-J., Zhang, D., FEI, Q., Li, J., & Sun, Y. (2014) · Oncology Reports · doi:10.3892/or.2014.3477 · Cited by 26
Anticancer Drugs and Potential Anticancer Leads Inspired by Natural Products
Kittakoop, P. (2015) · Studies in natural products chemistry · doi:10.1016/b978-0-444-63460-3.00005-5 · Cited by 22
Weber, A., Borghouts, C., Delis, N., Mack, L., Brill, B., Bernard, A.-C., Coqueret, O., & Groner, B. (2012) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2012-0014 · Cited by 16
STAT3 Inhibition Induces Apoptosis in Cancer Cells Independent of STAT1 or STAT2.
Shodeinde, A., Ginjupalli, K., Lewis, H. D., Riaz, S., & Barton, B. E. (2013) · PubMed · Cited by 13
Resveratrol Inhibitory Effects against a Malignant Tumor
Wcisło, G. (2013) · Polyphenols in Human Health and Disease · doi:10.1016/b978-0-12-398456-2.00096-7 · Cited by 5
Cited by
The Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
Self-citationLoh, C.-Y., Arya, A., Naema, A. F., Wong, W. F., Sethi, G., & Looi, C. Y. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00048 · Cited by 348
Self-citationPro-Apoptotic and Anti-Cancer Properties of Diosgenin: A Comprehensive and Critical Review
Sethi, G., Shanmugam, M., Warrier, S., Merarchi, M., Arfuso, F., Kumar, A., & Bishayee, A. (2018) · Nutrients · doi:10.3390/nu10050645 · Cited by 253
Self-citationTumor microenvironment in ovarian cancer: function and therapeutic strategy
Yang, Y., Yang, Y., Yang, J., Zhao, X., & Wei, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00758 · Cited by 218
Rah, B., Rather, R. A., Bhat, G. R., Baba, A. B., Mushtaq, I., Farooq, M., Yousuf, T., Dar, S. B., Parveen, S., Hassan, R., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.821344 · Cited by 202
Metadata
- Authors
- Chai, E. Z. P., Shanmugam, M. K., Arfuso, F., Dharmarajan, A., Wang, C., Kumar, A. P., Samy, R. P., Lim, L. H. K., Wang, L., Goh, B. C., Ahn, K. S., Hui, K. M., & Sethi, G.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 162
- Pages
- 86-97
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1812164980
- Cited by
- 263
- References
- 154
- FWCI
- 18.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.